世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界の人工知能医薬品開発市場の成長(現状と展望)2024-2030年


Global Artificial Intelligence Drug Development Market Growth (Status and Outlook) 2024-2030

LPI(LPインフォメーション)の最新調査によると、世界の人工知能医薬品開発市場規模は2023年に100万米ドルと評価されました。川下市場での需要の増加に伴い、人工知能医薬品開発は2030年までに100万米ドルの再調... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
LP Information
LPインフォメーション
2024年10月8日 US$3,660
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
112 英語

日本語のページは自動翻訳を利用し作成しています。


 

サマリー

LPI(LPインフォメーション)の最新調査によると、世界の人工知能医薬品開発市場規模は2023年に100万米ドルと評価されました。川下市場での需要の増加に伴い、人工知能医薬品開発は2030年までに100万米ドルの再調整規模になると予測され、レビュー期間中のCAGRは%である。
この調査レポートは、世界の人工知能医薬品開発市場の成長可能性を明らかにしています。人工知能医薬品開発は、今後の市場において安定した成長を示すと予想される。しかし、人工知能医薬品開発の普及には、製品の差別化、コスト削減、サプライチェーンの最適化が依然として重要です。市場関係者は、人工知能医薬品開発市場がもたらす莫大な機会を活用するために、研究開発への投資、戦略的パートナーシップの構築、進化する消費者の嗜好に合わせた製品提供を行う必要がある。
世界の医薬品市場は2022年に1,475億ドルに達し、今後6年間のCAGRは5%で成長する。医薬品市場には、化学医薬品と生物学的医薬品が含まれる。生物製剤は2022年に3810億ドルになると予想されている。これに対し、化学医薬品市場は2018年の1,050億米ドルから2022年には1,090億米ドルに増加すると推定されている。医薬品市場の要因としては、医療需要の増加、技術の進歩、慢性疾患の有病率の上昇、医薬品製造分野の開発に対する民間&政府機関からの資金提供の増加、医薬品の研究開発活動の活発化などが挙げられる。しかし、厳しい規制、研究開発費の高騰、特許切れといった課題にも直面している。企業は、市場での競争力を維持し、必要とする患者に確実に製品を届けるために、継続的に技術革新を行い、こうした課題に適応していく必要がある。さらに、COVID-19の大流行はワクチン開発とサプライチェーン管理の重要性を浮き彫りにし、製薬企業が公衆衛生の新たなニーズに機敏に対応する必要性をさらに強調している。
主な特徴
人工知能医薬品開発市場に関する本レポートは、様々な側面を反映し、業界に関する貴重な洞察を提供します。
市場規模と成長:この調査レポートは、人工知能医薬品開発市場の現在の規模と成長の概要を提供します。過去データ、タイプ別市場区分(例:薬剤設計、薬剤合成)、地域別内訳を含む場合があります。
市場促進要因と課題:政府規制、環境問題、技術進歩、消費者の嗜好の変化など、人工知能医薬品開発市場の成長を促進する要因を特定・分析することができます。また、インフラストラクチャーの制限、射程距離への不安、高額な初期費用など、業界が直面する課題も浮き彫りにすることができます。
競合情勢:この調査レポートは、人工知能医薬品開発市場内の競合状況の分析を提供しています。主要企業のプロフィール、市場シェア、戦略、製品提供などが含まれています。また、新興プレーヤーとその潜在的な市場への影響もハイライトできます。
技術開発:調査レポートは、人工知能医薬品開発業界における最新の技術開発を掘り下げることができます。これには、人工知能医薬品開発技術の進歩、人工知能医薬品開発の新規参入企業、人工知能医薬品開発の新規投資、人工知能医薬品開発の将来を形作るその他のイノベーションなどが含まれます。
川下の事業者の好み:このレポートは、人工知能医薬品開発市場における顧客の購買行動と採用動向を明らかにします。このレポートには、顧客の購買決定や人工知能医薬品開発製品の嗜好に影響を与える要因が含まれています。
政府の政策とインセンティブ調査レポートは、政府の政策やインセンティブが人工知能医薬品開発市場に与える影響を分析します。これには、人工知能医薬品開発市場の促進を目的とした規制枠組み、補助金、税制優遇措置などの評価が含まれます。また、市場成長促進におけるこれらの政策の有効性も評価します。
環境への影響と持続可能性調査レポートは、人工知能医薬品開発市場の環境への影響と持続可能性の側面を評価します。
市場予測と将来展望:実施した分析に基づいて、調査レポートは人工知能医薬品開発産業の市場予測と展望を提供します。これには、市場規模、成長率、地域動向、技術進歩や政策展開に関する予測などが含まれます。
提言と機会本レポートでは最後に、業界関係者、政策立案者、投資家への提言を行っています。市場関係者が新たなトレンドを活用し、課題を克服し、人工知能医薬品開発市場の成長と発展に貢献するための潜在的な機会を強調しています。
市場細分化:
人工知能医薬品開発市場は、タイプ別と用途別に分類されます。2019年から2030年までの期間について、セグメント間の成長により、タイプ別、アプリケーション別の消費額の正確な計算と予測を提供します。
タイプ別セグメント
医薬品設計
医薬品合成
その他
用途別セグメント
腫瘍
神経系
その他
本レポートではまた、市場を地域別に分けています:
南北アメリカ
アメリカ
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
中東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、主要な専門家から収集した情報、および企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。
インシリコメディシン
サイリカ
XtalPi社
エクスセンシア・リミテッド
アイキュア・エルエルシー
アトムワイズ
バイオビスタ社
Breg,Inc.
ヌメレート
クラウド・ファーマシューティカルズ
IBM
ニューメディイ
ベネボレントAI
ラム・セラピューティクス


ページTOPに戻る


目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Artificial Intelligence Drug Development Market Size 2019-2030
2.1.2 Artificial Intelligence Drug Development Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Artificial Intelligence Drug Development Segment by Type
2.2.1 Drug Design
2.2.2 Drug Synthesis
2.2.3 Other
2.3 Artificial Intelligence Drug Development Market Size by Type
2.3.1 Artificial Intelligence Drug Development Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Artificial Intelligence Drug Development Market Size Market Share by Type (2019-2024)
2.4 Artificial Intelligence Drug Development Segment by Application
2.4.1 Tumor
2.4.2 Nervous System
2.4.3 Other
2.5 Artificial Intelligence Drug Development Market Size by Application
2.5.1 Artificial Intelligence Drug Development Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Artificial Intelligence Drug Development Market Size Market Share by Application (2019-2024)
3 Artificial Intelligence Drug Development Market Size by Player
3.1 Artificial Intelligence Drug Development Market Size Market Share by Players
3.1.1 Global Artificial Intelligence Drug Development Revenue by Players (2019-2024)
3.1.2 Global Artificial Intelligence Drug Development Revenue Market Share by Players (2019-2024)
3.2 Global Artificial Intelligence Drug Development Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Artificial Intelligence Drug Development by Regions
4.1 Artificial Intelligence Drug Development Market Size by Regions (2019-2024)
4.2 Americas Artificial Intelligence Drug Development Market Size Growth (2019-2024)
4.3 APAC Artificial Intelligence Drug Development Market Size Growth (2019-2024)
4.4 Europe Artificial Intelligence Drug Development Market Size Growth (2019-2024)
4.5 Middle East & Africa Artificial Intelligence Drug Development Market Size Growth (2019-2024)
5 Americas
5.1 Americas Artificial Intelligence Drug Development Market Size by Country (2019-2024)
5.2 Americas Artificial Intelligence Drug Development Market Size by Type (2019-2024)
5.3 Americas Artificial Intelligence Drug Development Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artificial Intelligence Drug Development Market Size by Region (2019-2024)
6.2 APAC Artificial Intelligence Drug Development Market Size by Type (2019-2024)
6.3 APAC Artificial Intelligence Drug Development Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Artificial Intelligence Drug Development by Country (2019-2024)
7.2 Europe Artificial Intelligence Drug Development Market Size by Type (2019-2024)
7.3 Europe Artificial Intelligence Drug Development Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Artificial Intelligence Drug Development by Region (2019-2024)
8.2 Middle East & Africa Artificial Intelligence Drug Development Market Size by Type (2019-2024)
8.3 Middle East & Africa Artificial Intelligence Drug Development Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Artificial Intelligence Drug Development Market Forecast
10.1 Global Artificial Intelligence Drug Development Forecast by Regions (2025-2030)
10.1.1 Global Artificial Intelligence Drug Development Forecast by Regions (2025-2030)
10.1.2 Americas Artificial Intelligence Drug Development Forecast
10.1.3 APAC Artificial Intelligence Drug Development Forecast
10.1.4 Europe Artificial Intelligence Drug Development Forecast
10.1.5 Middle East & Africa Artificial Intelligence Drug Development Forecast
10.2 Americas Artificial Intelligence Drug Development Forecast by Country (2025-2030)
10.2.1 United States Artificial Intelligence Drug Development Market Forecast
10.2.2 Canada Artificial Intelligence Drug Development Market Forecast
10.2.3 Mexico Artificial Intelligence Drug Development Market Forecast
10.2.4 Brazil Artificial Intelligence Drug Development Market Forecast
10.3 APAC Artificial Intelligence Drug Development Forecast by Region (2025-2030)
10.3.1 China Artificial Intelligence Drug Development Market Forecast
10.3.2 Japan Artificial Intelligence Drug Development Market Forecast
10.3.3 Korea Artificial Intelligence Drug Development Market Forecast
10.3.4 Southeast Asia Artificial Intelligence Drug Development Market Forecast
10.3.5 India Artificial Intelligence Drug Development Market Forecast
10.3.6 Australia Artificial Intelligence Drug Development Market Forecast
10.4 Europe Artificial Intelligence Drug Development Forecast by Country (2025-2030)
10.4.1 Germany Artificial Intelligence Drug Development Market Forecast
10.4.2 France Artificial Intelligence Drug Development Market Forecast
10.4.3 UK Artificial Intelligence Drug Development Market Forecast
10.4.4 Italy Artificial Intelligence Drug Development Market Forecast
10.4.5 Russia Artificial Intelligence Drug Development Market Forecast
10.5 Middle East & Africa Artificial Intelligence Drug Development Forecast by Region (2025-2030)
10.5.1 Egypt Artificial Intelligence Drug Development Market Forecast
10.5.2 South Africa Artificial Intelligence Drug Development Market Forecast
10.5.3 Israel Artificial Intelligence Drug Development Market Forecast
10.5.4 Turkey Artificial Intelligence Drug Development Market Forecast
10.5.5 GCC Countries Artificial Intelligence Drug Development Market Forecast
10.6 Global Artificial Intelligence Drug Development Forecast by Type (2025-2030)
10.7 Global Artificial Intelligence Drug Development Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Insilico Medicine
11.1.1 Insilico Medicine Company Information
11.1.2 Insilico Medicine Artificial Intelligence Drug Development Product Offered
11.1.3 Insilico Medicine Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Insilico Medicine Main Business Overview
11.1.5 Insilico Medicine Latest Developments
11.2 Cyclica
11.2.1 Cyclica Company Information
11.2.2 Cyclica Artificial Intelligence Drug Development Product Offered
11.2.3 Cyclica Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Cyclica Main Business Overview
11.2.5 Cyclica Latest Developments
11.3 XtalPi Inc.
11.3.1 XtalPi Inc. Company Information
11.3.2 XtalPi Inc. Artificial Intelligence Drug Development Product Offered
11.3.3 XtalPi Inc. Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 XtalPi Inc. Main Business Overview
11.3.5 XtalPi Inc. Latest Developments
11.4 Exscientia Limited
11.4.1 Exscientia Limited Company Information
11.4.2 Exscientia Limited Artificial Intelligence Drug Development Product Offered
11.4.3 Exscientia Limited Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Exscientia Limited Main Business Overview
11.4.5 Exscientia Limited Latest Developments
11.5 AiCure, LLC
11.5.1 AiCure, LLC Company Information
11.5.2 AiCure, LLC Artificial Intelligence Drug Development Product Offered
11.5.3 AiCure, LLC Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 AiCure, LLC Main Business Overview
11.5.5 AiCure, LLC Latest Developments
11.6 Atomwise
11.6.1 Atomwise Company Information
11.6.2 Atomwise Artificial Intelligence Drug Development Product Offered
11.6.3 Atomwise Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Atomwise Main Business Overview
11.6.5 Atomwise Latest Developments
11.7 Biovista Inc.
11.7.1 Biovista Inc. Company Information
11.7.2 Biovista Inc. Artificial Intelligence Drug Development Product Offered
11.7.3 Biovista Inc. Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Biovista Inc. Main Business Overview
11.7.5 Biovista Inc. Latest Developments
11.8 Breg,Inc.
11.8.1 Breg,Inc. Company Information
11.8.2 Breg,Inc. Artificial Intelligence Drug Development Product Offered
11.8.3 Breg,Inc. Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Breg,Inc. Main Business Overview
11.8.5 Breg,Inc. Latest Developments
11.9 Numerate
11.9.1 Numerate Company Information
11.9.2 Numerate Artificial Intelligence Drug Development Product Offered
11.9.3 Numerate Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Numerate Main Business Overview
11.9.5 Numerate Latest Developments
11.10 Cloud Pharmaceuticals
11.10.1 Cloud Pharmaceuticals Company Information
11.10.2 Cloud Pharmaceuticals Artificial Intelligence Drug Development Product Offered
11.10.3 Cloud Pharmaceuticals Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Cloud Pharmaceuticals Main Business Overview
11.10.5 Cloud Pharmaceuticals Latest Developments
11.11 IBM
11.11.1 IBM Company Information
11.11.2 IBM Artificial Intelligence Drug Development Product Offered
11.11.3 IBM Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 IBM Main Business Overview
11.11.5 IBM Latest Developments
11.12 NuMedii
11.12.1 NuMedii Company Information
11.12.2 NuMedii Artificial Intelligence Drug Development Product Offered
11.12.3 NuMedii Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 NuMedii Main Business Overview
11.12.5 NuMedii Latest Developments
11.13 BenevolentAI
11.13.1 BenevolentAI Company Information
11.13.2 BenevolentAI Artificial Intelligence Drug Development Product Offered
11.13.3 BenevolentAI Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 BenevolentAI Main Business Overview
11.13.5 BenevolentAI Latest Developments
11.14 Lam Therapeutics
11.14.1 Lam Therapeutics Company Information
11.14.2 Lam Therapeutics Artificial Intelligence Drug Development Product Offered
11.14.3 Lam Therapeutics Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Lam Therapeutics Main Business Overview
11.14.5 Lam Therapeutics Latest Developments
12 Research Findings and Conclusion

 

ページTOPに戻る


 

Summary

According to our LPI (LP Information) latest study, the global Artificial Intelligence Drug Development market size was valued at US$ million in 2023. With growing demand in downstream market, the Artificial Intelligence Drug Development is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Artificial Intelligence Drug Development market. Artificial Intelligence Drug Development are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Artificial Intelligence Drug Development. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Artificial Intelligence Drug Development market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Artificial Intelligence Drug Development market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Artificial Intelligence Drug Development market. It may include historical data, market segmentation by Type (e.g., Drug Design, Drug Synthesis), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Artificial Intelligence Drug Development market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Artificial Intelligence Drug Development market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Artificial Intelligence Drug Development industry. This include advancements in Artificial Intelligence Drug Development technology, Artificial Intelligence Drug Development new entrants, Artificial Intelligence Drug Development new investment, and other innovations that are shaping the future of Artificial Intelligence Drug Development.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Artificial Intelligence Drug Development market. It includes factors influencing customer ' purchasing decisions, preferences for Artificial Intelligence Drug Development product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Artificial Intelligence Drug Development market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Artificial Intelligence Drug Development market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Artificial Intelligence Drug Development market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Artificial Intelligence Drug Development industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Artificial Intelligence Drug Development market.
Market Segmentation:
Artificial Intelligence Drug Development market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Drug Design
Drug Synthesis
Other
Segmentation by application
Tumor
Nervous System
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Insilico Medicine
Cyclica
XtalPi Inc.
Exscientia Limited
AiCure, LLC
Atomwise
Biovista Inc.
Breg,Inc.
Numerate
Cloud Pharmaceuticals
IBM
NuMedii
BenevolentAI
Lam Therapeutics



ページTOPに戻る


Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Artificial Intelligence Drug Development Market Size 2019-2030
2.1.2 Artificial Intelligence Drug Development Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Artificial Intelligence Drug Development Segment by Type
2.2.1 Drug Design
2.2.2 Drug Synthesis
2.2.3 Other
2.3 Artificial Intelligence Drug Development Market Size by Type
2.3.1 Artificial Intelligence Drug Development Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Artificial Intelligence Drug Development Market Size Market Share by Type (2019-2024)
2.4 Artificial Intelligence Drug Development Segment by Application
2.4.1 Tumor
2.4.2 Nervous System
2.4.3 Other
2.5 Artificial Intelligence Drug Development Market Size by Application
2.5.1 Artificial Intelligence Drug Development Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Artificial Intelligence Drug Development Market Size Market Share by Application (2019-2024)
3 Artificial Intelligence Drug Development Market Size by Player
3.1 Artificial Intelligence Drug Development Market Size Market Share by Players
3.1.1 Global Artificial Intelligence Drug Development Revenue by Players (2019-2024)
3.1.2 Global Artificial Intelligence Drug Development Revenue Market Share by Players (2019-2024)
3.2 Global Artificial Intelligence Drug Development Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Artificial Intelligence Drug Development by Regions
4.1 Artificial Intelligence Drug Development Market Size by Regions (2019-2024)
4.2 Americas Artificial Intelligence Drug Development Market Size Growth (2019-2024)
4.3 APAC Artificial Intelligence Drug Development Market Size Growth (2019-2024)
4.4 Europe Artificial Intelligence Drug Development Market Size Growth (2019-2024)
4.5 Middle East & Africa Artificial Intelligence Drug Development Market Size Growth (2019-2024)
5 Americas
5.1 Americas Artificial Intelligence Drug Development Market Size by Country (2019-2024)
5.2 Americas Artificial Intelligence Drug Development Market Size by Type (2019-2024)
5.3 Americas Artificial Intelligence Drug Development Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artificial Intelligence Drug Development Market Size by Region (2019-2024)
6.2 APAC Artificial Intelligence Drug Development Market Size by Type (2019-2024)
6.3 APAC Artificial Intelligence Drug Development Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Artificial Intelligence Drug Development by Country (2019-2024)
7.2 Europe Artificial Intelligence Drug Development Market Size by Type (2019-2024)
7.3 Europe Artificial Intelligence Drug Development Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Artificial Intelligence Drug Development by Region (2019-2024)
8.2 Middle East & Africa Artificial Intelligence Drug Development Market Size by Type (2019-2024)
8.3 Middle East & Africa Artificial Intelligence Drug Development Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Artificial Intelligence Drug Development Market Forecast
10.1 Global Artificial Intelligence Drug Development Forecast by Regions (2025-2030)
10.1.1 Global Artificial Intelligence Drug Development Forecast by Regions (2025-2030)
10.1.2 Americas Artificial Intelligence Drug Development Forecast
10.1.3 APAC Artificial Intelligence Drug Development Forecast
10.1.4 Europe Artificial Intelligence Drug Development Forecast
10.1.5 Middle East & Africa Artificial Intelligence Drug Development Forecast
10.2 Americas Artificial Intelligence Drug Development Forecast by Country (2025-2030)
10.2.1 United States Artificial Intelligence Drug Development Market Forecast
10.2.2 Canada Artificial Intelligence Drug Development Market Forecast
10.2.3 Mexico Artificial Intelligence Drug Development Market Forecast
10.2.4 Brazil Artificial Intelligence Drug Development Market Forecast
10.3 APAC Artificial Intelligence Drug Development Forecast by Region (2025-2030)
10.3.1 China Artificial Intelligence Drug Development Market Forecast
10.3.2 Japan Artificial Intelligence Drug Development Market Forecast
10.3.3 Korea Artificial Intelligence Drug Development Market Forecast
10.3.4 Southeast Asia Artificial Intelligence Drug Development Market Forecast
10.3.5 India Artificial Intelligence Drug Development Market Forecast
10.3.6 Australia Artificial Intelligence Drug Development Market Forecast
10.4 Europe Artificial Intelligence Drug Development Forecast by Country (2025-2030)
10.4.1 Germany Artificial Intelligence Drug Development Market Forecast
10.4.2 France Artificial Intelligence Drug Development Market Forecast
10.4.3 UK Artificial Intelligence Drug Development Market Forecast
10.4.4 Italy Artificial Intelligence Drug Development Market Forecast
10.4.5 Russia Artificial Intelligence Drug Development Market Forecast
10.5 Middle East & Africa Artificial Intelligence Drug Development Forecast by Region (2025-2030)
10.5.1 Egypt Artificial Intelligence Drug Development Market Forecast
10.5.2 South Africa Artificial Intelligence Drug Development Market Forecast
10.5.3 Israel Artificial Intelligence Drug Development Market Forecast
10.5.4 Turkey Artificial Intelligence Drug Development Market Forecast
10.5.5 GCC Countries Artificial Intelligence Drug Development Market Forecast
10.6 Global Artificial Intelligence Drug Development Forecast by Type (2025-2030)
10.7 Global Artificial Intelligence Drug Development Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Insilico Medicine
11.1.1 Insilico Medicine Company Information
11.1.2 Insilico Medicine Artificial Intelligence Drug Development Product Offered
11.1.3 Insilico Medicine Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Insilico Medicine Main Business Overview
11.1.5 Insilico Medicine Latest Developments
11.2 Cyclica
11.2.1 Cyclica Company Information
11.2.2 Cyclica Artificial Intelligence Drug Development Product Offered
11.2.3 Cyclica Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Cyclica Main Business Overview
11.2.5 Cyclica Latest Developments
11.3 XtalPi Inc.
11.3.1 XtalPi Inc. Company Information
11.3.2 XtalPi Inc. Artificial Intelligence Drug Development Product Offered
11.3.3 XtalPi Inc. Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 XtalPi Inc. Main Business Overview
11.3.5 XtalPi Inc. Latest Developments
11.4 Exscientia Limited
11.4.1 Exscientia Limited Company Information
11.4.2 Exscientia Limited Artificial Intelligence Drug Development Product Offered
11.4.3 Exscientia Limited Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Exscientia Limited Main Business Overview
11.4.5 Exscientia Limited Latest Developments
11.5 AiCure, LLC
11.5.1 AiCure, LLC Company Information
11.5.2 AiCure, LLC Artificial Intelligence Drug Development Product Offered
11.5.3 AiCure, LLC Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 AiCure, LLC Main Business Overview
11.5.5 AiCure, LLC Latest Developments
11.6 Atomwise
11.6.1 Atomwise Company Information
11.6.2 Atomwise Artificial Intelligence Drug Development Product Offered
11.6.3 Atomwise Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Atomwise Main Business Overview
11.6.5 Atomwise Latest Developments
11.7 Biovista Inc.
11.7.1 Biovista Inc. Company Information
11.7.2 Biovista Inc. Artificial Intelligence Drug Development Product Offered
11.7.3 Biovista Inc. Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Biovista Inc. Main Business Overview
11.7.5 Biovista Inc. Latest Developments
11.8 Breg,Inc.
11.8.1 Breg,Inc. Company Information
11.8.2 Breg,Inc. Artificial Intelligence Drug Development Product Offered
11.8.3 Breg,Inc. Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Breg,Inc. Main Business Overview
11.8.5 Breg,Inc. Latest Developments
11.9 Numerate
11.9.1 Numerate Company Information
11.9.2 Numerate Artificial Intelligence Drug Development Product Offered
11.9.3 Numerate Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Numerate Main Business Overview
11.9.5 Numerate Latest Developments
11.10 Cloud Pharmaceuticals
11.10.1 Cloud Pharmaceuticals Company Information
11.10.2 Cloud Pharmaceuticals Artificial Intelligence Drug Development Product Offered
11.10.3 Cloud Pharmaceuticals Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Cloud Pharmaceuticals Main Business Overview
11.10.5 Cloud Pharmaceuticals Latest Developments
11.11 IBM
11.11.1 IBM Company Information
11.11.2 IBM Artificial Intelligence Drug Development Product Offered
11.11.3 IBM Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 IBM Main Business Overview
11.11.5 IBM Latest Developments
11.12 NuMedii
11.12.1 NuMedii Company Information
11.12.2 NuMedii Artificial Intelligence Drug Development Product Offered
11.12.3 NuMedii Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 NuMedii Main Business Overview
11.12.5 NuMedii Latest Developments
11.13 BenevolentAI
11.13.1 BenevolentAI Company Information
11.13.2 BenevolentAI Artificial Intelligence Drug Development Product Offered
11.13.3 BenevolentAI Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 BenevolentAI Main Business Overview
11.13.5 BenevolentAI Latest Developments
11.14 Lam Therapeutics
11.14.1 Lam Therapeutics Company Information
11.14.2 Lam Therapeutics Artificial Intelligence Drug Development Product Offered
11.14.3 Lam Therapeutics Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Lam Therapeutics Main Business Overview
11.14.5 Lam Therapeutics Latest Developments
12 Research Findings and Conclusion

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医薬)の最新刊レポート


よくあるご質問


LP Information社はどのような調査会社ですか?


LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/05 10:26

151.38 円

159.59 円

194.97 円

ページTOPに戻る